Maureen Okam

RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates

Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson

Refining the value of secretory phospholipase A₂ as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)